NCT00116896View on ClinicalTrials.gov

Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

December 31, 2004

Conditions
Advanced Solid Tumors
Interventions
DRUG

OSI-7904L

DRUG

Cisplatin

Trial Locations (2)

78229

Institute for Drug DevelopmentCancer Therapy & Research Center, San Antonio

37232-6307

Vanderbilt Universtiy Medical Center, Nashville

Sponsors
All Listed Sponsors
lead

OSI Pharmaceuticals

INDUSTRY

NCT00116896 - Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors | Biotech Hunter | Biotech Hunter